soo-KRAL-fate 
Unlabeled Use:
Absorption: Systemic absorption is minimal (<5%).
Distribution: Unknown.
Metabolism/Excretion: >90% is eliminated in the feces.
Half-life: 6–20 hr.
Contraindicated in:
Use Cautiously in:
Derm: pruritus, rashes.
Endo: hyperglycemia (with suspension).
GI: constipation, diarrhea, dry mouth, gastric discomfort, indigestion, nausea.
Neuro: dizziness, drowsiness.
Misc: HYPERSENSITIVITY REACTIONS (INCLUDING ANAPHYLAXIS AND ANGIOEDEMA).
Drug-Drug:
Treatment of Ulcers
Prevention of Ulcers
Gastroesophageal Reflux
Stomatitis
(Generic available)
NDC Code*